GlassScriptPhysician profile
Michel Antoine
NPI 1033144589
$449.22
in general payments reported to CMS, 2019-2025
7 companies · $20.34 in 2025
The $20.34 reported for 2025 was less than what a typical Addiction Medicine (Internal Medicine) provider received nationally (typical 2025 total: $124).
See the full distribution for Addiction Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.31 · 2020: $84.15 · 2021: $54.97 · 2022: $67.35 · 2023: $41.52 · 2024: $104 · 2025: $20.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $186.63 | 2019-2024 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $125.26 | 2019-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $55.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $24.25 | 2020 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Lilly USA, LLC | $20.34 | 2025 | Zepbound, Mounjaro |
| Indivior INC. | $15.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michel Antoine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.